Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study.

doi:10.1186/s12933-026-03351-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Composite C-reactive protein-triglyceride-glucose adiposity indices and incident cardiovascular-liver-metabolic multimorbidity: a prospective cohort study.

Cardiovascular diabetology - 26 Aug 2026

Chen Jing, Sun Zhonghua, Qiu Jiajun, Zhou Zhongqing, Ma Kaiqi, Liang Yongxin, Li Chunqun, Liang Shicong

Abstract excerpt

BACKGROUND: The C-reactive protein-triglyceride-glucose index (CTI) is a comprehensive marker that reflects inflammation and insulin resistance. Cardiovascular-liver-metabolic (CLM) diseases caused by multiple factors may be related to insulin resistance, obesity, metabolism, etc. Our aim is to explore the association between the fat index derived from CTI and a newly identified surrogate-defined CLM...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adiposity
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to C-Reactive Protein

Share to Cardiovascular Diseases

Share to Incidence

Share to Longitudinal Studies

Share to Predictive Value of Tests

Share to Triglycerides

Source

Open in PubMed Open full text

Identifiers

PMID: 42665793
DOI: 10.1186/s12933-026-03351-5
PMCID: PMC13525692

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.